Skip to content

Dianthus Therapeutics

US · DNTH #2155 by market cap Listed 1970
84.88 -0.52 -0.61%
Live - 5344 symbols - heartbeat 336s ago · 2026-10-07 21:26
After-hours 84.88 0.00%
Overnight 85.24 +0.42%
Market cap
4.75B
P/B
4.05
EPS
-4.20
Reader sentiment Are you bullish or bearish on DNTH?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    H.C. Wainwright Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating, Maintains Target Price $130
    Market Newswire · 2026/6/12
  • Rating change
    Jefferies Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating, Maintains Target Price $132
    Market Newswire · 2026/6/15
  • Rating change
    A Quick Look at Today's Ratings for Dianthus Therapeutics(DNTH.US), With a Forecast Between $122 to $150
    Market Newswire · 2026/8/5
  • Rating change
    Evercore Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating, Raises Target Price to $120
    Market Newswire · 2026/5/11
  • Rating change
    Raymond James Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating
    Market Newswire · 2026/6/13
  • J.P. Morgan Initiates Dianthus Therapeutics(DNTH.US) With Buy Rating, Announces Target Price $135
    Market Newswire · 2026/9/11
  • Rating change
    Truist Financial Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating
    Market Newswire · 2026/6/15
  • Rating change
    Wedbush Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating, Maintains Target Price $105
    Market Newswire · 2026/6/15
  • Rating change
    Stifel Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating, Maintains Target Price $133
    Market Newswire · 2026/8/14
  • Rating change
    Evercore Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating, Raises Target Price to $134
    Market Newswire · 2026/8/10
  • Rating change
    A Quick Look at Today's Ratings for Dianthus Therapeutics(DNTH.US), With a Forecast Between $105 to $132
    Market Newswire · 2026/6/11
  • H.C. Wainwright Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating, Maintains Target Price $158
    Market Newswire · 2026/10/1
  • Rating change
    Citi Initiates Dianthus Therapeutics(DNTH.US) With Buy Rating, Announces Target Price $156
    Market Newswire · 2026/9/4
  • William Blair Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating
    Market Newswire · 2026/9/18
  • Rating change
    A Quick Look at Today's Ratings for Dianthus Therapeutics(DNTH.US), With a Forecast Between $122 to $200
    Market Newswire · 2026/8/6
  • J.P. Morgan Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating
    Market Newswire · 2026/9/24
  • Rating change
    Wells Fargo Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating, Maintains Target Price $135
    Market Newswire · 2026/6/17
  • Rating change
    Truist Financial Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating, Announces Target Price $128
    Market Newswire · 2026/8/6
  • LifeSci Capital Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating, Maintains Target Price $125
    Market Newswire · 2026/9/30
  • Rating change
    Wedbush Maintains Dianthus Therapeutics(DNTH.US) With Buy Rating, Raises Target Price to $105
    Market Newswire · 2026/6/12

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-07 21:26:06 · For reference only, not investment advice and not tailored to your situation.